GenSight Biologics
Agent36Agent Readiness: 36/100. Below median. Measured by StartupHub.ai. Median 41.Trust71Data Trust: 71/100. Above median. Measured by StartupHub.ai. Median 61.Developing innovative gene therapies to preserve or restore vision in patients with retinal diseases.
About
GenSight Biologics is a biotechnology company advancing gene therapy for neurodegenerative ophthalmic diseases. They are developing treatments for conditions like Leber Hereditary Optic Neuropathy (LHON), Retinitis Pigmentosa (RP), and Geographic Atrophy in Dry-AMD, utilizing technologies such as gene therapy, mitochondrial targeting sequences, and optogenetics. Their clinical development includes GS010 (lenadogene nolparvovec) and GS030.
Listed competitors
Also in this space
Pioneering vision restoration therapies for severe retinal degenerations.
Shares Biotechnology, Healthcare
Epicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
Shares Biotechnology, Gene Therapy
A biotechnology company developing genetic therapies for rare disorders.
Shares Biotechnology, Healthcare
Clinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
Shares Biotechnology, Gene Therapy
A nonprofit research organization leveraging AI and biotechnology to understand and treat complex diseases.
Shares Biotechnology, Gene Therapy
Developing gene editing therapies to lower cholesterol.
Shares Biotechnology, Gene Therapy
Key facts
- Website
- gensight-biologics.com
- Headquarters
- Paris, France
- Founded
- 2012
- Total funding
- $5M (Unknown)
- Business model
- B2B
Funding rounds
| Date | Round | Amount | Lead investors |
|---|---|---|---|
| 10 Mar 2026 | Undisclosed round | $2M | |
| 7 Jan 2026 | Post IPO | $3M |
Tech stack
Detected on gensight-biologics.com, last scanned 1 Nov 2026. Run your own scan
- Compliance
- GDPR, CCPA
- Frontend
- jQuery
- Analytics
- Google Analytics 4
- SEO
- Yoast SEO
- CMS / Builders
- WordPress
- CDN
- Cloudflare
- Email provider
- Microsoft 365
GenSight Biologics scores 47. Does yours?
That is its Ahrefs DR: the backlink strength of a domain, on the Ahrefs 0 to 100 scale. Paste your website and you get yours in about a minute.
Frequently asked
Is GenSight Biologics trustworthy and reputable?
StartupHub's Data Trust & Reputation score for GenSight Biologics is 71 out of 100, a generally safe rating, based on site security posture, privacy practices, malware and phishing checks, and public reputation signals.
How much funding has GenSight Biologics raised?
GenSight Biologics has raised a total of $5M in funding. The most recent round on record is Unknown.
Public record
SEC filings, insider activity, nonprofit links and pay benchmarks for GenSight Biologics
